Blog
RSS FeedPosted by Michael Wonder on 15 Nov 2018
'Death sentence': One-in-a-million rare cancers get the 'sorting hat' treatment
13 November 2018 - For people with the rarest of cancers, the hope of survival or an effective treatment can ...
Posted by Michael Wonder on 03 Sep 2018
Medicare-funded cancer genetic tests: a note of caution
3 September 2018 - Clinicians need appropriate education and support in keeping pace with the genomics revolution. ...
Posted by Michael Wonder on 04 Jun 2018
Rule out chemotherapy for early breast cancer - but first take a $5,000 test
4 June 2018 - There is good news for women with early breast cancer, but for Australians it comes at ...
Posted by Michael Wonder on 19 Feb 2018
August 2018 PBAC special meeting
19 February 2018 - Options for listing of pan-tumour indications for PDL-1 cancer immunotherapies on the PBS. ...
Posted by Michael Wonder on 18 Feb 2017
The refusal of Medicare to fund a $60 blood test means cancer patients miss out on treatment
19 February 2017 - Mother of two Lisa Briggs and thousands of other lung cancer patients battling the nation’s deadliest ...
Posted by Michael Wonder on 12 Apr 2016
PBAC Guidelines review - co-dependent technologies
12 April 2016 - The public consultation process for the assessment of co-dependent technology chapter of the draft revised PBAC Guidelines ...
Posted by Michael Wonder on 11 Mar 2016
PBAC Guidelines review
11 March 2016 - The assessment of co-dependent technology chapter of the draft revised PBAC Guidelines has now been published on ...